Rinri Therapeutics

University of Sheffield spinout. Developer of Rincell-1, a cell therapy using lab-grown otic neural progenitor cells; its first MHRA-approved human trial has not started yet (registry start date now Sep 2027), targeting neural hearing loss rather than tinnitus directly.